Yong Yu, SVP, Clinical Development at GENELUX Corp (GNLX), sold 4,192 shares at $3.36 ($16K) on 2025-08-21, disclosed to the SEC on 2025-12-11.
Open-market sale of $16k GNLX by SVP, Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.36 | 3,219 | $11K | 67.4% |
| 2 | $5.37 | 973 | $5K | 32.6% |
| Total | $3.83 avg | 4,192 | $16K | 100% |
| Filing → |
| GNLX | SELL | 2026-05-12 | $2K | — | Filing → |
| GNLX | SELL | 2026-03-26 | $2K | — | Filing → |
| GNLX | SELL | 2025-05-13 | $16K | — | Filing → |